AngioScore, Inc., a developer of novel angioplasty catheters for use in the treatment of cardiovascular disease, today announced that preliminary data from the First-In-Human (FIH) Study (“PATENT-C”) of the Drug-Coated AngioSculpt Scoring Balloon Catheter will be presented at the Transcatheter Cardiovascular Therapeutics (TCT) Conference in San Francisco the week of October 28, 2013.
Help employers find you! Check out all the jobs and post your resume.
